Empagliflozin on Patients With Preserved Heart Failure

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The proposed research in this application will investigate the effect of empagliflozin on cardiac remodeling in patients with heart failure with preserved ejection fraction.
Epistemonikos ID: cf4e3c324fe31d7d6cc9bd7bed088702749169f7
First added on: Aug 09, 2025